512 followers
232 followers
RT @ByAmyBrown: Re ELAD Alzheimer's trial, $NVO's CSO says secondary cognitive measures might be too subtle to expect much, points out that…
3,631 followers
Re ELAD Alzheimer's trial, $NVO's CSO says secondary cognitive measures might be too subtle to expect much, points out that primary endpoint is major readout: change in cerebral glucose metabolic rate. https://t.co/WtM8nBuuUk
4,512 followers
RT @OxPsychiatry: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised co…